基于深圳新产业和爱尔眼科投资医疗市场的比较分析

Study on Private Capital's Participation in the National Health Care Reform

目前是国家医疗体制改革的关键时期,国家鼓励民营资本参与其中,来推进医疗体制改革。一方面能够发挥民营资本的新兴力量为社会建立更多的优质医疗资源,为广大国民提供更好的医疗服务;另一方面投资者也能从中获得更高的投资回报率。通过对眼科医疗行业最具有代表性的两个公司深圳新产业与爱尔眼科的比较分析,得出两者所代表的投资模式哪一种更适合当前及可预测的未来的医疗环境的结论。

At present, China is in the critical period of medical system reform. In order to promote the reform of medical system, the government encourages the participation of private enterprises. For one thing, private entrepreneurs, as an emerging force, can provide excellent medical facilities for society. As a result, better medical care will be supplied for the society. For another, investors will make more profit on investment. This article makes comparative analysis of Shenzhen New Medical Industry Development Co. , Ltd and Aier Eye Hospital Group Co. , Ltd. and comes to the conclusion that which mode is more suitable for the current and future healthcare environment.